Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR-NET anti-inflammatory treatment trial for bronchiectasis
ISRCTN17596258Phase 2Recruiting
- Sponsor
- University of Dundee
- Start
- Nov 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of disulfiram, dipyridamole and doxycycline in bronchiectasis (4 arms), sponsored by University of Dundee. Primary endpoint: Sputum neutrophil elastase activity. Started Nov 2024; status: recruiting.
02
Drugs
disulfiramdipyridamoledoxycycline
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ISRCTN17596258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17596258.